|
Glen UnySUPPORT
Our original Universal Support (20-5000) has been discontinued since complete dephosphorylation using ammonium hydroxide, AMA and anhydrous methylamine gas takes longer than most companies wish to allocate. A recent development has been the use of a support based on a molecule which is “conformationally preorganized” to accelerate the dephosphorylation reaction.1,2 By using a rigid bicyclic molecule on the support, it was hoped that the molecule’s conformation would facilitate the formation of the cyclic phosphate transition state, thereby stimulating the rate of dephosphorylation. It was found that the rate of elimination is markedly faster than the original Universal Support.
The structure of Glen UnySupport is shown below. The N-phenyl version, developed at Isis Pharmaceuticals as UnyLinker™, is available from several companies for large scale oligo synthesis. Glen UnySupport is the N-methyl version, which is preferred for high throughput oligonucleotide synthesis since methylamine rather than aniline is formed on deprotection. We are happy to offer Glen UnySupport in a variety of popular formats under license from Isis Pharmaceuticals.
| 20-5040-01 |
0.1g |
11.00 |
| (500Å CPG) |
20-5040-02 |
0.25g |
25.00 |
| |
20-5040-10 |
1.0g |
95.00 |
| 1 µmole columns |
20-5140-41 |
Pack of 4 |
60.00 |
| 0.2 µmole columns |
20-5140-42 |
Pack of 4 |
40.00 |
| 40 nmole columns |
20-5140-45 |
Pack of 4 |
40.00 |
| 10 µmole column (TWIST Format) |
20-5140-13 |
Pack of 1 |
100.00 |
| 1 µmole columns |
26-5140-51 |
Pack of 10 |
150.00 |
| 0.2 µmole columns |
26-5140-52 |
Pack of 10 |
100.00 |
| 40 nmole columns |
26-5140-55 |
Pack of 10 |
100.00 |
| 1 µmole columns |
20-5240-41 |
Pack of 4 |
60.00 |
| 0.2 µmole columns |
20-5240-42 |
Pack of 4 |
40.00 |
| 40 nmole columns |
20-5240-45 |
Pack of 4 |
40.00 |
| 15 µmole column (TWIST Format) |
20-5240-14 |
Pack of 1 |
150.00 |
| 1 µmole columns |
20-5140-91 |
Pack of 96 |
375.00 |
| 0.2 µmole columns |
20-5140-92 |
Pack of 96 |
250.00 |
| 40 nmole columns |
20-5140-95 |
Pack of 96 |
250.00 |
| 20-5041-01 |
0.1g |
11.00 |
| (1000Å CPG) |
20-5041-02 |
0.25g |
25.00 |
| |
20-5041-10 |
1.0g |
95.00 |
|
REFERENCES
(1) A.P. Guzaev, and M. Manoharan, J Am Chem Soc, 2003, 125, 2380-2381.
(2) R.K. Kumar, A.P. Guzaev, C. Rentel, and V.T. Ravikumar, Tetrahedron, 2006, 62, 4528.
ELIMINATION CONDITIONS
| Reagent |
Conditions |
| Ammonium hydroxide |
80°C/2h |
|
55°C/8h |
| Ammonium hydroxide/ |
80°C/0.5h |
| 40% Methylamine (AMA) |
65°C/1h |
|
55°C/8h |
INTELLECTUAL PROPERTY
This product is covered by US Patent 7,202,264 owned by Isis Pharmaceuticals, Inc.
OTHER INSTRUMENT TYPES
If you would like another type of vial/column add the following to the end of the catalog number.
Applied Biosystems 3900 |
A |
Expedite |
E |
Mermade |
M |
Please inquire for availability
of columns for other
instrument types.
|
|
UNIVERSAL SUPPORT
Traditional procedures in oligonucleotide synthesis require that the solid support contains the first nucleoside which is destined to become the nucleoside at the 3’-terminus of the synthetic oligonucleotide. This situation therefore requires that an inventory of all four regular nucleoside supports must be maintained. At the same time, oligonucleotides with unusual nucleosides, available as phosphoramidites but not as supports, at the 3’-terminus can not be readily prepared. However, the most worrisome aspect of this situation is the potential for a mistake to be made in the selection of the column containing the 3’-nucleoside. This potential for error may be fairly low in regular column-type synthesizers, but it is especially significant in the new generation of parallel synthesizers where 96, 192 wells or even more may contain all four supports in a defined grid.
A universal support for preparing regular oligonucleotides must allow the elimination, during the cleavage and deprotection steps, of the terminal phosphodiester linkage along with the group originally attached to the support.
A support which has the potential to be universal for the production of oligonucleotides containing a 3’-hydroxyl group has been described.1 The base-mediated elimination of the terminal phosphodiester group must proceed promptly under conditions comparable with routine deprotection strategies and some suggestions are shown to the left.
| 20-5000-xx |
|
|
| Discontinued: Use UnySupport above |
20-5100-xx |
|
|
| |
20-5200-xx |
|
|
| 25-5000-01 |
0.1g |
15.00 |
| |
25-5000-02 |
0.25g |
30.00 |
| |
25-5000-10 |
1.0g |
115.00 |
| 20-5001-01 |
0.1g |
11.00 |
| |
20-5001-02 |
0.25g |
25.00 |
| |
20-5001-10 |
1.0g |
95.00 |
| 0.2µmole columns |
20-5001-92 |
Pack of 96 |
250.00 |
| 40 nmole column |
20-5001-95 |
Pack of 96 |
250.00 |
02 |
|
REFERENCE
(1) S. Scott, P. Hardy, R.C. Sheppard, and
M.J. McLean, Innovations and Perspectives in Solid Phase Synthesis, 3rd
International Symposium, 1994, Ed. Roger Epton, Mayflower Worldwide, 115-124.
ELIMINATION CONDITIONS |
Ammonium hydroxide |
80ºC/8h min. |
Ammonium hydroxide/40% Methylamine
(AMA) |
55ºC/17h
80ºC/3h min. |
40% Methylamine |
55ºC/8h |
0.4M NaOH
in methanol/water (4:1) |
80ºC/0.5h
55ºC/3h
RT/17h |
INTELLECTUAL PROPERTY
These products are supplied under license from
Avecia Ltd. US Patent 5,681,945 and corresponding patents issued in
other countries.
Universal Support

OTHER INSTRUMENT TYPES All If you would like another type of vial/column add the following to the end of the catalog number.
Applied Biosystems 3900 |
A |
Expedite |
E |
Mermade |
M |
Please inquire for availability
of columns for other
instrument types.
|
|
Universal Support II / III
The key step in the use of any universal support in oligonucleotide synthesis is the dephosphorylation of the 3’-phosphate group to form the desired 3’-hydroxyl group. Azhayev1,2 has excelled in the investigation of neighboring group assistance in the dephosphorylation reaction. Amide groups may be considered to be weak N-H acids and can display basic properties in ammonium hydroxide or aqueous methylamine. (±)-3-Amino-1,2-propanediol was used to form a novel universal support. In our original US II support, a succinate linker attaches the 3-amino group to the support and the 2-OH is protected with a base-labile group to set up an amide assisted elimination in mildly basic conditions. In this way, the dephosphorylation reaction would eliminate the desired 3’-OH oligonucleotide into solution and the product of any ß-elimination competing side reaction would remain bound to the support. A further improvement has been achieved by using a carbamate group to connect the universal linker to the support, now called Universal Support III. The structures of the two supports are shown below right. Because the universal linker is unchanged and the succinate or carbamate groups remain attached to the support, we use the same catalog numbers for US II and III. Using Universal Support II or III, an oligo yield of > 80% can be achieved on CPG supports and > 95% on polymeric supports, with purity equivalent to the same oligo prepared normally.
Conditions for Cleavage and Deprotection are outlined in the table opposite. Universal Support II/III has been shown to generate oligonucleotides with the same efficacy in polymerase extension reactions as regular oligos. Despite the mild elimination reaction, oligonucleotides up to 75mer in length can be prepared routinely without loss of oligo during the synthesis cycles. This support is also used for the production of siRNA oligos.
| 20-5010-01 |
0.1g |
11.00 |
| (500Å CPG) |
20-5010-02 |
0.25g |
25.00 |
| |
20-5010-10 |
1.0g |
95.00 |
| 27-5010-01 |
0.1g |
15.00 |
| |
27-5010-02 |
0.25g |
35.00 |
| |
27-5010-10 |
1.0g |
95.00 |
| 1 µmole columns |
20-5110-41 |
Pack of 4 |
60.00 |
| 0.2 µmole columns |
20-5110-42 |
Pack of 4 |
40.00 |
| 40 nmole columns |
20-5110-45 |
Pack of 4 |
40.00 |
| 10 µmole column (TWIST Format) |
20-5110-13 |
Pack of 1 |
100.00 |
| 1 µmole columns |
20-5210-41 |
Pack of 4 |
60.00 |
| 0.2 µmole columns |
20-5210-42 |
Pack of 4 |
40.00 |
| 40 nmole columns |
20-5210-45 |
Pack of 4 |
40.00 |
| 15 µmole column (TWIST Format) |
20-5210-14 |
Pack of 1 |
150.00 |
|
| 1 µmole columns |
20-5110-91 |
Pack of 96 |
375.00 |
| 0.2 µmole columns |
20-5110-92 |
Pack of 96 |
250.00 |
| 40 nmole columns |
20-5110-95 |
Pack of 96 |
250.00 |
|
| 1 µmole columns |
27-5110-91 |
Pack of 96 |
375.00 |
| 0.2 µmole columns |
27-5110-92 |
Pack of 96 |
250.00 |
| 40 nmole columns |
27-5110-95 |
Pack of 96 |
250.00 |
| 1 µmole columns |
26-5110-51 |
Pack of 10 |
150.00 |
| 0.2 µmole columns |
26-5110-52 |
Pack of 10 |
100.00 |
| 40 nmole columns |
26-5110-55 |
Pack of 10 |
100.00 |
|
| 1 µmole columns |
27-5110-51 |
Pack of 10 |
150.00 |
| 0.2 µmole columns |
27-5110-52 |
Pack of 10 |
100.00 |
| 40 nmole columns |
27-5110-55 |
Pack of 10 |
100.00 |
|
REFERENCES
(1) A.V. Azhayev, Tetrahedron, 1999,
55, 787-800.
(2) A.V. Azhayev and M. Antopolsky, Tetrahedron, 2001, 57, 4977-4986.
INTELLECTUAL PROPERTY
This product is covered by US Patent No.:
6,770,754 and European Patent No.: 1404695.
CLEAVAGE AND DEPROTECTION
Cleavage
For standard and UltraFast deprotection protocols, cleave the oligo
from the support using 2M ammonia in methanol at room temperature for
30 minutes. (Only for oligonucleotides greater than 50 nucleotides in
length, rinse the support with a further volume of water. Combine the
two washes and evaporate to dryness.)
Deprotection
Standard
Add 1 volume of 30% ammonium hydroxide, seal and
deprotect using the conditions appropriate for removal of the protecting
groups on the nucleobases.
UltraFast
Add 1 volume of AMA (ammonium hydroxide/40% aqueous methylamine 1:1)
seal and deprotect at 65°C for 10 minutes.
UltraMild Using Ammonium Hydroxide
Add 1 volume of ammonium hydroxide, seal and leave at room temperature
for 8 hours.
UltraMild Cleavage and Deprotection
Using Potassium Carbonate in Methanol
Cleave the oligo from the support using 50 mM potassium carbonate in
methanol at room temperature for 30 minutes. Seal and leave overnight
at room temperature.
Universal Support II
Universal Support III PS
|
Q-SUPPORTS
Oligonucleotides are routinely prepared on supports to which
the first nucleoside is attached via a succinate linkage. Over the years,
the succinate linkage has demonstrated stability during the synthesis
process but has sufficient lability to be cleaved quickly in the deprotection
step. However, if the cleavage step is carried out with ammonium hydroxide
manually or on the synthesizer, it consumes one hour of precious time
while releasing only about 80% of the oligonucleotide. This step is, therefore,
a bottleneck in the productivity of many synthesis groups.
Is it possible to find a replacement to the succinate group
which offers good stability to the synthesis reagents while offering a
much faster cleavage step? The oxalate group has been shown to be very
labile during cleavage but its stability to the normal synthesis reagents
is not good, requiring changes for successful use. In a practical but
elegant study1 of various bifunctional carboxylic acids, Richard
Pon’s group identified hydroquinone-O,O’-diacetic acid as
the most satisfactory alternative to the succinate group. Nucleosides
with this linker arm (Q-linker) are attached to supports with the same
ease as the succinyl linker arm.
The cleavage time in ammonium hydroxide at room temperature
was found to be 2 minutes, but what about the stability during synthesis?
How significant was premature cleavage of oligonucleotide on the synthesizer
because of the basic reagents in the capping mixes and oxidizer? Pon showed
that the Q-linker is stable to the capping reagents but very slightly
labile to the oxidizer (8% cleavage in overnight exposure which would
correspond to about 2,000 normal synthesis cycles).
We tested the significance of premature cleavage by preparing
sixteen 20mer oligonucleotides on a 0.2 µmole scale, eight with
succinate and eight with Q-linkers. The succinate supported oligos were
cleaved for 1 hour at room temperature, while those on the Q-support were
cleaved for 2 minutes. Both sets were then deprotected normally with ammonium
hydroxide. The Q-supports actually gave 5% better yields of product than
the succinate supports. Oligo purities were equivalent in both sets.
The Q-linker is absolutely compatible with all hydrolytic cleavage procedures,
but especially mild procedures like potassium carbonate in methanol. Pon
also showed that it is preferable for RNA supports, improving the cleavage
time for 2’-silyl protected nucleoside supports from 2 hours (60-65%
cleavage) to 5 minutes (95% cleavage).
We are offering Q-linkers on 500Å CPG in 0.2 and 1µmole scales.
The four regular nucleosides are offered, as well as a Universal Support.
| 21-2000-01 |
21-2010-01 |
21-2013-01 |
21-2029-01 |
21-2030-01 |
|
0.1g |
11.00 |
| 21-2000-02 |
21-2010-02 |
21-2013-02 |
21-2029-02 |
21-2030-02 |
|
0.25g |
25.00 |
| 21-2000-10 |
21-2010-10 |
21-2013-10 |
21-2029-10 |
21-2030-10 |
|
1.0g |
95.00 |
| 21-2100-41 |
21-2110-41 |
21-2113-41 |
21-2129-41 |
21-2130-41 |
|
4X1µm |
60.00 |
| 21-2100-42 |
21-2110-42 |
21-2113-42 |
21-2129-42 |
21-2130-42 |
|
4X0.2µm |
40.00 |
| 21-2200-41 |
21-2210-41 |
21-2213-41 |
21-2229-41 |
21-2230-41 |
|
4X1µm |
60.00 |
| 21-2200-42 |
21-2210-42 |
21-2213-42 |
21-2229-42 |
21-2230-42 |
|
4X0.2µm |
40.00 |
| |
|
|
|
|
21-5000-01 |
0.1g |
|
| |
|
|
|
|
21-5000-02 |
0.25g |
|
| |
|
|
|
|
21-5000-10 |
1.0g |
|
|
REFERENCE
(1) R.T. Pon and S.Y. Yu, Tetrahedron
Lett, 1997, 38, 3327-3330.
INTELLECTUAL PROPERTY
Q-Supports are supplied under license
from University Technologies International LP (UTI LP).
(2 minutes cleavage) |
(60 minutes cleavage) |
132 ODU* |
125 ODU* |
*Average crude
yield from eight 1µmole columns deprotected normally. |
OTHER INSTRUMENT TYPES
All minor bases, RNA products and modifiers are packaged in septum-capped vials suitable for ABI and other instruments. If you would like another type of vial/column add the following to the end of the catalog number.
Expedite |
E |
Beckman Oligo 1000 |
B |
Pharmacia Gene Assembler |
P |
Mermade |
M |
Applied Biosystems 3900 |
A |
Expedite |
E |
Mermade |
M |
Please inquire for availability
of columns for other
instrument types.
|
|
HIGH LOAD CPG
Our high loading support is based on controlled pore silica and it retains the usual 500Å pores. The spacer is also conventional. The only significant difference is the loading which is in the range 80 - 130µmoles/g or about 2.5 times the loading of normal 500Å CPG. Typical loadings for our high load CPG are in the 100 - 120µmoles/g range. As a consequence of the high loading, this support should not be used for sequences longer than 40mers. This high loading support is available in columns for most synthesizers. The 2.5µmole column is identical to our standard 1µmole column (with the exception of the loading). It should be used on occasions when greater than 1µmole is desired but when a 10 or 15µmole synthesis is too high. It should be run using the 1µmole cycle. The 25µmole column is identical to the 10µmole column used on Applied Biosystems synthesizers. It is run using the 10µmole cycle. The 35µmole column is used as an alternative to the 15µmole Expedite column. Again no changes to the standard cycle are recommended. The support is of course available in bulk for use on large-scale synthesizers. A word of caution is in order. When using a column with a higher load than recommended by the instrument manufacturer, there is a much smaller margin for error. All reagents must be fresh and anhydrous diluent and activator must be used. Should you decide to prepare higher-loading columns, ensure that the molar excess of monomer to support nucleoside is at least 5X and preferably 10X.
25-2100-46 |
25-2110-46 |
25-2120-46 |
25-2130-46 |
|
4X2.5µm |
75.00 |
| |
25-2100-17 |
25-2110-17 |
25-2120-17 |
25-2130-17 |
|
1X25µm |
125.00 |
25-2200-46 |
25-2210-46 |
25-2220-46 |
25-2230-46 |
|
4X2.5µm |
75.00 |
| |
25-2200-18 |
25-2210-18 |
25-2220-18 |
25-2230-18 |
|
1X35µm |
185.00 |
| |
25-2000-02 |
25-2010-02 |
25-2020-02 |
25-2030-02 |
|
0.25g |
25.00 |
| |
25-2000-10 |
25-2010-10 |
25-2020-10 |
25-2030-10 |
|
1.0g |
90.00 |
25-5000-01 |
0.1g |
15.00 |
|
25-5000-02 |
0.25g |
30.00 |
|
25-5000-10 |
1.0g |
115.00 |
|
OTHER INSTRUMENT TYPES
All minor bases, RNA products and modifiers are packaged in septum-capped vials suitable for ABI and other instruments. If you would like another type of vial/column add the following to the end of the catalog number.
Expedite |
E |
Beckman Oligo 1000 |
B |
Pharmacia Gene Assembler |
P |
Mermade |
M |
Applied Biosystems 3900 |
A |
Expedite |
E |
Mermade |
M |
Please inquire for availability
of columns for other
instrument types.
|
|
http://www.glenres.com/Catalog/supports.html
|
|